Picture of Olema Pharmaceuticals logo

OLMA — Olema Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Olema Oncology Reports Third Quarter 2022 Financial Results

Nov 8 (Reuters) - Olema Pharmaceuticals Inc  OLMA.O :
    * OLEMA ONCOLOGY REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES CORPORATE UPDATE
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES POSITION
OF
$222.6 MILLION AS OF SEPTEMBER 30, 2022
    * QTRLY LOSS PER SHARE $0.57
    * Q3 EARNINGS PER SHARE VIEW $-0.77 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9b3KXD 
Further company coverage:  OLMA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Olema Pharmaceuticals

See all news